Hospital

Extended infusion piperacillin/tazobactam was associated with lower odds of 14-day mortality compared to standard infusion piperacillin/tazobactam.

Elranatamab is an investigational B-cell maturation antigen CD3-targeted bispecific antibody that may become the next standard of care for multiple myeloma, according to researchers.

Results of the ACTIV-6 study showed that high dose ivermectin use did not demonstrate a clinical benefit for mild to moderate COVID-19.

Hospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.

Increasing interventions for affordable housing and food security could contribute to reduced rates of heart disease in lower income communities.

Pharmacy technicians and pharmacy technician leadership from UPMC Presbyterian discuss how they became pharmacy technicians in health-system pharmacies.

If approved, the vaccine would be the first immunization for use in pregnant individuals to help protect against the complications of respiratory syncytial virus in infants from birth through 6 months.

Including the ThinPrep Pap Test improves access to the benefits of the human papillomavirus (HPV) assay, which is the only FDA-approved assay that tests for an extended set of HPV types individually.

Substance use disorder is a significant social, economic, and public health crisis, with far too few individuals receiving the treatment they need, particularly among communities of color.

In a subgroup analysis, patients with COVID-19 who received conventional oxygen support also benefitted, having 20 fewer deaths per 1000 patients when given remdesivir.

Sparsentan decreased proteinuria by nearly 50% in patients with IgA nephropathy, which may slow kidney function decline.

Positive data on the novel prostate cancer combination treatment was presented at the 2023 American Society of Clinical Oncology Genitourinary Cancers Symposium.

Olaparib with abiraterone increased survival in patients with metastatic prostate cancer compared to the current standard of care, according to a session at the ASCO Genitourinary Cancers Symposium.

The ability—or lack thereof—to procure drugs can drive prices up and decrease patient accessibility.

With recent outbreaks of measles and other vaccine-preventable diseases, vaccinations are more important than ever.

The FDA approved darolutamide in 2019 for the treatment of patients with nonmetastatic castration-resistant prostate cancer based improved metastasis-free survival.

One of the major concerns about getting a flu vaccine is its safety for women during pregnancy.

In addition to vital historical contributions, pharmacists of color are crucial in reaching marginalized communities and providing culturally competent care.

Managing understaffing and increasingly demanding workflows is an ongoing challenge in pharmacy.

The findings are the first to explain the mechanisms of any Kawasaki disease, a rare childhood inflammatory condition that is triggered by different viruses.

Austedo XR will be available in 3 extended-release tablet strengths, which provides an updated regimen that may result in a lower pill count for patients.

Letermovir is the only drug approved for prophylaxis of cytomegalovirus (CMV) infection for patients who are CMV-seropositive and have received an allogeneic HSCT.

Incidence of regional tumor recurrence in patients with HR–positive breast cancer did not significantly differ between patients who received post operational radiotherapy.

A specialty pharmacy can effectively dispense, monitor, and follow-up with transplant patients who are maintained on the standard triple-drug immunosuppression regimen.

Antibodies from an original COVID-19 vaccination may treat the mRNA booster vaccine as a virus that needs to be cleared.

The latest data indicate that the formulation can provide up to 6 months of full protection against multiple virus challenges.

The risk of new-onset cardiometabolic diseases was significantly elevated post-COVID-19 infection compared to pre-COVID-19 infection.

Health care providers prescribe naloxone to 1 in every 70 patients prescribed a high-dose opioid medication.